• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状指蛋白 31 通过抑制 YAP/PD-L1 抑制三阴性乳腺癌细胞的进展和免疫逃逸。

RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.

机构信息

Xinxiang Key Laboratory of Tumor Migration and Invasion Precision Medicine, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, 453003, Henan Province, People's Republic of China.

Molecular Biology Laboratory, First People's Hospital of Shangqiu, Shangqiu, City, 476000, Henan Province, People's Republic of China.

出版信息

J Exp Clin Cancer Res. 2022 Dec 29;41(1):364. doi: 10.1186/s13046-022-02576-y.

DOI:10.1186/s13046-022-02576-y
PMID:36581998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9801641/
Abstract

BACKGROUND

Recently genome-based studies revealed that the abnormality of Hippo signaling is pervasive in TNBC and played important role in cancer progression. RING finger protein 31 (RNF31) comes to RING family E3 ubiquitin ligase. Our previously published studies have revealed RNF31 is elevated in ER positive breast cancer via activating estrogen signaling and suppressing P53 pathway.

METHODS

We used several TNBC cell lines and xenograft models and performed immuno-blots, QPCR, in vivo studies to investigate the function of RNF31 in TNBC progression.

RESULT

Here, we demonstrate that RNF31 plays tumor suppressive function in triple negative breast cancer (TNBC). RNF31 depletion increased TNBC cell proliferation and migration in vitro and in vitro. RNF31 depletion in TNBC coupled with global genomic expression profiling indicated Hippo signaling could be the potential target for RNF31 to exert its function. Further data showed that RNF31 depletion could increase the level of YAP protein, and Hippo signaling target genes expression in several TNBC cell lines, while clinical data illustrated that RNF31 expression correlated with longer relapse-free survival in TNBC patients and reversely correlated with YAP protein level. The molecular biology assays implicated that RNF31 could associate with YAP protein, facilitate YAP poly-ubiquitination and degradation at YAP K76 sites. Interestingly, RNF31 could also repress PDL1 expression and sensitive TNBC immunotherapy via inhibiting Hippo/YAP/PDL1 axis.

CONCLUSIONS

Our study revealed the multi-faced function of RNF31 in different subtypes of breast malignancies, while activation RNF31 could be a plausible strategy for TNBC therapeutics.

摘要

背景

最近基于基因组的研究表明,Hippo 信号异常在三阴性乳腺癌(TNBC)中普遍存在,并在癌症进展中发挥重要作用。RING 指蛋白 31(RNF31)属于 RING 家族 E3 泛素连接酶。我们之前的研究表明,RNF31 通过激活雌激素信号和抑制 P53 通路在 ER 阳性乳腺癌中上调。

方法

我们使用了几种 TNBC 细胞系和异种移植模型,并进行了免疫印迹、QPCR 和体内研究,以研究 RNF31 在 TNBC 进展中的作用。

结果

在这里,我们证明 RNF31 在三阴性乳腺癌(TNBC)中发挥肿瘤抑制作用。RNF31 耗竭增加了 TNBC 细胞的体外和体内增殖和迁移。TNBC 中 RNF31 的耗竭与全基因组表达谱分析表明,Hippo 信号可能是 RNF31 发挥其功能的潜在靶点。进一步的数据表明,RNF31 耗竭可以增加几个 TNBC 细胞系中 YAP 蛋白和 Hippo 信号靶基因的表达,而临床数据表明 RNF31 表达与 TNBC 患者无复发生存期延长相关,与 YAP 蛋白水平呈负相关。分子生物学检测表明,RNF31 可以与 YAP 蛋白结合,促进 YAP 在 YAP K76 位点的多泛素化和降解。有趣的是,RNF31 还可以通过抑制 Hippo/YAP/PDL1 轴来抑制 PDL1 的表达,从而提高 TNBC 免疫治疗的敏感性。

结论

我们的研究揭示了 RNF31 在不同亚型乳腺癌中的多方面功能,而激活 RNF31 可能是 TNBC 治疗的一种可行策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/7b5a55a1c771/13046_2022_2576_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/1de692b48054/13046_2022_2576_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/209d772627f4/13046_2022_2576_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/fdc6af715d3a/13046_2022_2576_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/9761177f184f/13046_2022_2576_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/4424975fb231/13046_2022_2576_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/8e05c76de86e/13046_2022_2576_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/7b5a55a1c771/13046_2022_2576_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/1de692b48054/13046_2022_2576_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/209d772627f4/13046_2022_2576_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/fdc6af715d3a/13046_2022_2576_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/9761177f184f/13046_2022_2576_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/4424975fb231/13046_2022_2576_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/8e05c76de86e/13046_2022_2576_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e98/9801641/7b5a55a1c771/13046_2022_2576_Fig7_HTML.jpg

相似文献

1
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.环状指蛋白 31 通过抑制 YAP/PD-L1 抑制三阴性乳腺癌细胞的进展和免疫逃逸。
J Exp Clin Cancer Res. 2022 Dec 29;41(1):364. doi: 10.1186/s13046-022-02576-y.
2
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.RBCK1 是通过 hippo/YAP 轴抑制三阴性乳腺癌的内源性抑制剂。
Cell Commun Signal. 2022 Oct 24;20(1):164. doi: 10.1186/s12964-022-00963-8.
3
ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.ZNF213 通过 Hippo/YAP 信号通路负向调控三阴性乳腺癌的进展。
Cancer Sci. 2021 Jul;112(7):2714-2727. doi: 10.1111/cas.14916. Epub 2021 May 3.
4
RNF181 modulates Hippo signaling and triple negative breast cancer progression.RNF181调节Hippo信号通路和三阴性乳腺癌进展。
Cancer Cell Int. 2020 Jul 6;20:291. doi: 10.1186/s12935-020-01397-3. eCollection 2020.
5
UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced transcription in triple negative breast cancer.UBR5 通过增强 IFN-γ 诱导的转录促进三阴性乳腺癌的肿瘤免疫逃逸。
Theranostics. 2022 Jul 4;12(11):5086-5102. doi: 10.7150/thno.74989. eCollection 2022.
6
Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187.泛素连接酶RNF187对Hippo信号通路及三阴性乳腺癌进展的调控
Oncogenesis. 2020 Mar 20;9(3):36. doi: 10.1038/s41389-020-0220-5.
7
p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target.p53通过miR-34a下调PD-L1表达以抑制三阴性乳腺癌细胞的生长:一个潜在的临床免疫治疗靶点。
Mol Biol Rep. 2023 Jan;50(1):577-587. doi: 10.1007/s11033-022-08047-z. Epub 2022 Nov 9.
8
[Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].[大风子素通过CNOT4介导的YAP泛素化和降解抑制三阴性乳腺癌的恶性进展]
Zhongguo Zhong Yao Za Zhi. 2023 Aug;48(16):4483-4492. doi: 10.19540/j.cnki.cjcmm.20230510.706.
9
RING finger protein 31 promotes p53 degradation in breast cancer cells.环状结构域蛋白31促进乳腺癌细胞中p53的降解。
Oncogene. 2016 Apr 14;35(15):1955-64. doi: 10.1038/onc.2015.260. Epub 2015 Jul 6.
10
Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization.自噬通过 YAP 的核定位促进三阴性乳腺癌转移。
Biochem Biophys Res Commun. 2019 Dec 3;520(2):263-268. doi: 10.1016/j.bbrc.2019.09.133. Epub 2019 Oct 5.

引用本文的文献

1
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities.YAP/TAZ的翻译后修饰:分子机制与治疗机遇
Cell Mol Biol Lett. 2025 Jul 17;30(1):83. doi: 10.1186/s11658-025-00760-4.
2
Nuclear-localized metabolic enzymes: emerging key players in tumor epigenetic regulation.核定位代谢酶:肿瘤表观遗传调控中新兴的关键因子
Mol Cell Biochem. 2025 May 28. doi: 10.1007/s11010-025-05316-w.
3
Unveiling the nexus of p53 and PD-L1: insights into immunotherapy resistance mechanisms in hepatocellular carcinoma.

本文引用的文献

1
Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma.肿瘤细胞 PD-L1 表达与纳武单抗单药治疗转移性透明细胞肾细胞癌反应的转录组学相关性。
Clin Cancer Res. 2022 Sep 15;28(18):4045-4055. doi: 10.1158/1078-0432.CCR-22-0923.
2
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.组合免疫疗法克服三阴性乳腺癌中 MYC 驱动的免疫逃逸。
Nat Commun. 2022 Jun 27;13(1):3671. doi: 10.1038/s41467-022-31238-y.
3
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC).
揭示p53与PD-L1的联系:深入了解肝细胞癌免疫治疗耐药机制
Am J Cancer Res. 2025 Apr 15;15(4):1410-1435. doi: 10.62347/BRTO3272. eCollection 2025.
4
RNF135 promotes the stemness of breast cancer cells by ubiquitinating and degrading DDX58.RNF135通过泛素化和降解DDX58来促进乳腺癌细胞的干性。
Transl Oncol. 2025 Apr;54:102321. doi: 10.1016/j.tranon.2025.102321. Epub 2025 Feb 21.
5
RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancer.RNF31通过维持ALYREF在人三阴性乳腺癌中的细胞质-细胞核穿梭诱导紫杉醇耐药。
Clin Transl Med. 2025 Feb;15(2):e70203. doi: 10.1002/ctm2.70203.
6
Determining new disulfidptosis-associated lncRNA signatures pertinent to breast cancer prognosis and immunological microenvironment.确定与乳腺癌预后和免疫微环境相关的新的二硫化物诱导细胞程序性坏死相关长链非编码RNA特征。
Transl Cancer Res. 2024 Nov 30;13(11):5815-5829. doi: 10.21037/tcr-24-513. Epub 2024 Nov 21.
7
OPN-Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH-Associated Liver Fibrosis.骨桥蛋白介导的肝细胞E4BP4与肝星状细胞之间的串扰促进与MASH相关的肝纤维化。
Adv Sci (Weinh). 2024 Dec;11(47):e2405678. doi: 10.1002/advs.202405678. Epub 2024 Oct 29.
8
UBR1 promotes anaplastic thyroid carcinoma progression via stabilizing YAP through monoubiquitylation.UBR1 通过单泛素化稳定 YAP 促进间变性甲状腺癌进展。
Sci Rep. 2024 Aug 22;14(1):19496. doi: 10.1038/s41598-024-70458-8.
9
The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics.间充质干细胞在癌症中的作用及其在癌症治疗中的应用前景。
MedComm (2020). 2024 Jul 28;5(8):e663. doi: 10.1002/mco2.663. eCollection 2024 Aug.
10
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.泛素化和去泛素化在癌症中的作用:从机制到新的治疗方法。
Mol Cancer. 2024 Jul 25;23(1):148. doi: 10.1186/s12943-024-02046-3.
焦点黏着激酶(FAK)- Hippo/YAP 转导信号介导 S100A8/A9-RAGE 系统在三阴性乳腺癌(TNBC)中发挥的刺激作用。
J Exp Clin Cancer Res. 2022 Jun 3;41(1):193. doi: 10.1186/s13046-022-02396-0.
4
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer.RBMS1 的缺失通过促进三阴性乳腺癌中的 PD-L1 检查点阻断来增强抗肿瘤免疫。
Cell Death Differ. 2022 Nov;29(11):2247-2261. doi: 10.1038/s41418-022-01012-0. Epub 2022 May 10.
5
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment.LY3200882 和 PD-L1 siRNA 的定点递呈程序增强了肿瘤微环境重构,从而提升三阴性乳腺癌的免疫治疗效果。
Biomaterials. 2022 May;284:121518. doi: 10.1016/j.biomaterials.2022.121518. Epub 2022 Apr 12.
6
KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling.KMT5A 甲基化的 SNIP1 通过激活 YAP 信号促进三阴性乳腺癌转移。
Nat Commun. 2022 Apr 21;13(1):2192. doi: 10.1038/s41467-022-29899-w.
7
Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing.Rnf31 和 Vps4b 的缺失使胰腺癌对 T 细胞介导的杀伤敏感。
Nat Commun. 2022 Apr 4;13(1):1804. doi: 10.1038/s41467-022-29412-3.
8
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.用于定义单独使用抗PD-1抗体或联合伊匹单抗治疗转移性黑色素瘤的反应和生存情况的临床模型
J Clin Oncol. 2022 Apr 1;40(10):1068-1080. doi: 10.1200/JCO.21.01701. Epub 2022 Feb 10.
9
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes.多组学分析鉴定三阴性乳腺癌亚型的治疗脆弱性。
Nat Commun. 2021 Nov 1;12(1):6276. doi: 10.1038/s41467-021-26502-6.
10
Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity in KRAS-Mutant Non-Small Cell Lung Cancer.褪黑素下调 KRAS 突变型非小细胞肺癌中 PD-L1 的表达并调节肿瘤免疫。
Int J Mol Sci. 2021 May 26;22(11):5649. doi: 10.3390/ijms22115649.